Bortenat 3.5mg/ml Injection
In stock
Description
Bortenat 3.5mg/ML Injection (Bortezomib) is an anti-cancer medication used to treat multiple myeloma and mantle-cell lymphoma. It works by inhibiting protein breakdown in cells, causing cancer cell death. Administered intravenously or subcutaneously by a professional, it may cause side effects like nausea, fatigue, diarrhea, and low blood cell counts.
Specifications
| Strength | 3.5 mg/vial. |
|---|---|
| Main Ingredients | Bortezomib |
| Uses | Multiple Myeloma and Mantle Cell Lymphoma |
| Storage | Store below 25°C |
| Pack | vial |
